<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>04260595531884</udiDi>
    <basicUdiDi>B-04260595531884</basicUdiDi>
    <tradeName>opticol® GL OSD (Amostra)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>41099900L</reference>
    <placedOnMarketCountry>Portugal</placedOnMarketCountry>
    <lastUpdated>2026-06-17T23:53:43.525Z</lastUpdated>
  </row>
  <row>
    <udiDi>04260595531877</udiDi>
    <basicUdiDi>B-04260595531877</basicUdiDi>
    <tradeName>opticol® GL OSD</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>41099800L</reference>
    <placedOnMarketCountry>Portugal</placedOnMarketCountry>
    <lastUpdated>2026-06-17T23:53:41.767Z</lastUpdated>
  </row>
  <row>
    <udiDi>04260595531860</udiDi>
    <basicUdiDi>B-04260595531860</basicUdiDi>
    <tradeName>opticol® GL</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>6128041L</reference>
    <placedOnMarketCountry>Portugal</placedOnMarketCountry>
    <lastUpdated>2026-06-17T23:53:40.859Z</lastUpdated>
  </row>
  <row>
    <udiDi>04260595531853</udiDi>
    <basicUdiDi>B-04260595531853</basicUdiDi>
    <tradeName>opticol® OSD (Amostra)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>41095600L</reference>
    <placedOnMarketCountry>Portugal</placedOnMarketCountry>
    <lastUpdated>2026-06-17T23:53:39.010Z</lastUpdated>
  </row>
  <row>
    <udiDi>04260595531839</udiDi>
    <basicUdiDi>B-04260595531839</basicUdiDi>
    <tradeName>opticol®</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>6112425L</reference>
    <placedOnMarketCountry>Portugal</placedOnMarketCountry>
    <lastUpdated>2026-06-17T23:53:30.200Z</lastUpdated>
  </row>
  <row>
    <udiDi>04260595531815</udiDi>
    <basicUdiDi>B-04260595531815</basicUdiDi>
    <tradeName>omniVIT® Augentropfen</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>41104101L</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T23:53:28.466Z</lastUpdated>
  </row>
  <row>
    <udiDi>04260595531808</udiDi>
    <basicUdiDi>B-04260595531808</basicUdiDi>
    <tradeName>Okuzell® classic</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>41069400L</reference>
    <placedOnMarketCountry>Czechia</placedOnMarketCountry>
    <lastUpdated>2026-06-17T23:53:27.510Z</lastUpdated>
  </row>
  <row>
    <udiDi>04260595531792</udiDi>
    <basicUdiDi>B-04260595531792</basicUdiDi>
    <tradeName>Okuzell® classic</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>41057000L</reference>
    <placedOnMarketCountry>Bulgaria</placedOnMarketCountry>
    <lastUpdated>2026-06-17T23:53:25.748Z</lastUpdated>
  </row>
  <row>
    <udiDi>04260595531785</udiDi>
    <basicUdiDi>B-04260595531785</basicUdiDi>
    <tradeName>Okuzell® classic</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>41038600L</reference>
    <placedOnMarketCountry>Austria</placedOnMarketCountry>
    <lastUpdated>2026-06-17T23:53:24.802Z</lastUpdated>
  </row>
  <row>
    <udiDi>04260595531778</udiDi>
    <basicUdiDi>B-04260595531778</basicUdiDi>
    <tradeName>Ocutears®</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>41059000L</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-06-17T23:53:23.000Z</lastUpdated>
  </row>
  <row>
    <udiDi>04260595531662</udiDi>
    <basicUdiDi>B-04260595531662</basicUdiDi>
    <tradeName>Vizik Alergia</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>41115500L</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-06-17T23:53:13.993Z</lastUpdated>
  </row>
  <row>
    <udiDi>04260595531655</udiDi>
    <basicUdiDi>B-04260595531655</basicUdiDi>
    <tradeName>Vizik ochi uscaţi și obosiţi</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>41093100L</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-06-17T23:53:12.189Z</lastUpdated>
  </row>
  <row>
    <udiDi>04260595531617</udiDi>
    <basicUdiDi>B-04260595531617</basicUdiDi>
    <tradeName>McMed® Augentropfen</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>41105500L</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T23:53:09.510Z</lastUpdated>
  </row>
  <row>
    <udiDi>04260595531600</udiDi>
    <basicUdiDi>B-04260595531600</basicUdiDi>
    <tradeName>Lakroft</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>41046200L</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-06-17T23:53:08.604Z</lastUpdated>
  </row>
  <row>
    <udiDi>04260595531518</udiDi>
    <basicUdiDi>B-04260595531518</basicUdiDi>
    <tradeName>HyloPan (MONODOSE)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>41104300L</reference>
    <placedOnMarketCountry>Greece</placedOnMarketCountry>
    <lastUpdated>2026-06-17T23:52:57.779Z</lastUpdated>
  </row>
  <row>
    <udiDi>04260595531501</udiDi>
    <basicUdiDi>B-04260595531501</basicUdiDi>
    <tradeName>Vizik oční kapky zvlhčující</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>41114200L</reference>
    <placedOnMarketCountry>Czechia</placedOnMarketCountry>
    <lastUpdated>2026-06-17T23:52:55.978Z</lastUpdated>
  </row>
  <row>
    <udiDi>04260595531495</udiDi>
    <basicUdiDi>B-04260595531495</basicUdiDi>
    <tradeName>HYDRO med Blue</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>41117200L</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T23:52:55.081Z</lastUpdated>
  </row>
  <row>
    <udiDi>04260595531488</udiDi>
    <basicUdiDi>B-04260595531488</basicUdiDi>
    <tradeName>HYALOVET GEL</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>41031101L</reference>
    <placedOnMarketCountry>Greece</placedOnMarketCountry>
    <lastUpdated>2026-06-17T23:52:53.283Z</lastUpdated>
  </row>
  <row>
    <udiDi>04260595531471</udiDi>
    <basicUdiDi>B-04260595531471</basicUdiDi>
    <tradeName>HYALOVET®</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>41011502L</reference>
    <placedOnMarketCountry>Greece</placedOnMarketCountry>
    <lastUpdated>2026-06-17T23:52:52.380Z</lastUpdated>
  </row>
  <row>
    <udiDi>04260595531464</udiDi>
    <basicUdiDi>B-04260595531464</basicUdiDi>
    <tradeName>HyaloTears (MONODOSE)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>41102200L</reference>
    <placedOnMarketCountry>Greece</placedOnMarketCountry>
    <lastUpdated>2026-06-17T23:52:50.583Z</lastUpdated>
  </row>
</eudamedExport>